Status:
COMPLETED
Hyperbaric on Pulmonary Functions in Post Covid -19 Patients.
Lead Sponsor:
Cairo University
Conditions:
Post COVID-19 Patients
Eligibility:
All Genders
21-66 years
Phase:
NA
Brief Summary
Purpose of the study is to investigate the effect of hyperbaric oxygen on FVC, FEV1 and on oxygen saturation in post-COVID-19 patients, The effect of breathing exercises in form of diaphragmatic breat...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- 1\. post Covid -19 patients (2weeks after recovery).
- post Covid -19 patients with deficiency in forced vital capacity (less than 80%) forced expiratory volume (less than 80%) lower oxygen saturation (90%-95%).
- age (21-66)years old.
- both gender.
- BMI 25.0-29.9.
- Exclusion Criteria:
- COPD or other respiratory diseases.
- Neurological disease.
- mental illness.
- Critically ill patients with intubation.
- smokers.
- Inner ear diseases.
- pregnancy.
Exclusion
Key Trial Info
Start Date :
March 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT05977166
Start Date
March 7 2022
End Date
June 1 2023
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Physical Therapy
Giza, Egypt